Harvard Bioscience, Inc. to Present at the Jefferies Global Healthcare Conference on June 5, 2024

Rhea-AI Summary

Harvard Bioscience announced that CEO Jim Green and CFO Jennifer Cote will present at the Jefferies Global Healthcare Conference on June 5, 2024.

The event will be held at the Marriott Marquis, New York City, from 2:00 to 2:25 PM Eastern Time.

The presentation will be webcast live via the Harvard Bioscience investor relations website, with a replay available afterwards.

Additionally, the company will host one-on-one meetings with investors during the conference.

For scheduling these meetings, investors can contact healthcareconference@jefferies.com.

Positive

• Harvard Bioscience's participation in a major healthcare conference increases visibility and investor engagement.
• The presentation will be webcast live, enhancing accessibility for a broader audience.
• One-on-one meetings with investors could foster stronger investor relations and potential investments.

Negative

• The announcement lacks detailed financial results or new business developments.
• No new clinical data or significant product announcements were made, which may not satisfy investors looking for concrete advancements.

HOLLISTON, Mass., May 23, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be presenting to investors at the Jefferies Global Healthcare Conference at the Marriott Marquis in New York City on June 5, 2024.

The Company’s presentation will be 2:00-2:25 PM ET on June 5th. The presentation will be webcast live and can be accessed through the investor relations section of the Harvard Bioscience website at https://investor.harvardbioscience.com. A replay will be available shortly after the presentation has concluded.

Harvard Bioscience will also host one-on-one meetings with investors in conjunction with the Conference. To schedule a one-on-one meeting, please contact healthcareconference@jefferies.com.

About Harvard Bioscience, Inc.  

Harvard Bioscience, Inc. is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, pharmaceutical and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. Our customers range from renowned academic institutions and government laboratories to the world’s leading pharmaceutical, biotechnology and contract research organizations. With operations in North America, Europe, and China, we sell through a combination of direct and distribution channels to customers around the world.  

For more information, please visit our website at
www.harvardbioscience.com

Company Contact:

Harvard Bioscience
Jennifer Cote, Chief Financial Officer
(508) 893-3120

Investor Contacts:

Three Part Advisors
Sandy Martin / Erol Girgin / William Shelmire
HBIO@threepa.com
(214) 616-2207

FAQ

When is Harvard Bioscience's presentation at the Jefferies Global Healthcare Conference?

Harvard Bioscience will present on June 5, 2024, from 2:00 to 2:25 PM ET.

Where is the Jefferies Global Healthcare Conference held?

The conference will be held at the Marriott Marquis, New York City.

Who will represent Harvard Bioscience at the Jefferies Global Healthcare Conference?

CEO Jim Green and CFO Jennifer Cote will represent Harvard Bioscience.

Will the Harvard Bioscience presentation be available online?

Yes, the presentation will be webcast live on the Harvard Bioscience investor relations website, with a replay available shortly after.

How can investors schedule one-on-one meetings with Harvard Bioscience?

Investors can contact healthcareconference@jefferies.com to schedule one-on-one meetings.